Investment
Features
FeesSafety
Academy
More
Pluang+

Compare YieldMax MSTR Option Income Strategy ETF (MSTY) vs Revolution Medicines Inc. Common Stock (RVMD) Price & Performance

YieldMax MSTR Option Income Strategy ETFTrade
Revolution Medicines Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

YieldMax MSTR Option Income Strategy ETF vs Revolution Medicines Inc. Common Stock — how do they compare? YieldMax MSTR Option Income Strategy ETF trades at $15.85 (market cap $1.11B), while Revolution Medicines Inc. Common Stock trades at $188.5 (market cap $43.07B). The key difference: Revolution Medicines Inc. Common Stock is far larger — about 38.8× YieldMax MSTR Option Income Strategy ETF's market cap, and Revolution Medicines Inc. Common Stock is trading nearer its 52-week high, YieldMax MSTR Option Income Strategy ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold YieldMax MSTR Option Income Strategy ETF for 30 Days and Revolution Medicines Inc. Common Stock for 0 Days on average.

MSTYRVMD
Market Cap
$1.11B$43.07B
Volume
3,805,3841,184,841
Sector
Income / Options OverlayHealth
52-Week High
$67.85$221.15
52-Week Low
$11.55$47.50
Typical Hold Time
30 Days0 Days
Enterprise Value
—$39.77B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

YieldMax MSTR Option Income Strategy ETF

MSTY, the YieldMax MSTR Option Income Strategy ETF, trades at $15.83, down 5.61% with a bearish technical signal. The fund generates weekly distributions through options strategies on MicroStrategy stock, with recent payouts ranging from $0.16 to $0.34. Despite high distribution rates exceeding 100% annualized, the fund has experienced significant NAV erosion, declining approximately 34% over six months according to 24/7 Wall Street analysis from July 2026.

The outlook remains challenging as MSTY's strategy sacrifices capital appreciation for income generation. While the high distribution rate provides income, the structural erosion of NAV presents substantial risk. Investors face the dual challenge of receiving taxable distributions while experiencing principal decline, making this suitable only for those prioritizing current income over capital preservation.

Revolution Medicines Inc. Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

MSTY
83% Buy17% Sell
Avg holding period · 30 Days
RVMD
100% Buy0% Sell
Avg holding period · 0 Days

About YieldMax MSTR Option Income Strategy ETF

MSTY is an actively managed ETF that pursues a synthetic covered call strategy on MicroStrategy Incorporated (MSTR) stock. The fund primarily sells call options on MSTR and invests in U.S. Treasury securities and other high-quality collateral. Its goal is to generate monthly income from the option premiums. This strategy provides exposure to the volatile, Bitcoin-correlated growth potential of MSTR while seeking to deliver a high yield, though it caps the potential capital appreciation of the stock.

Read more on MSTY →

About Revolution Medicines Inc. Common Stock

Revolution Medicines develops precision medicines for cancer. Its programs focus on targeting RAS-driven cancers and related signaling pathways.

Read more on RVMD →